Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor
Clinical trial NCT02724527 · UNKNOWN
Trial details
- NCT number
- NCT02724527
- Sponsor
- Nivalis Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-04-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.